Table 3:
Imaging features of pancreatitis
Variables | Diabetes=Yes (n=24) | Diabetes=No (n=373) | OR (95% CI) of Diabetes |
---|---|---|---|
Imaging studies performed | |||
ERCP | 7 (29%) | 153 (41%) | 0.59 (0.24, 1.46) |
CT scan | 10 (42%) | 164 (44%) | 0.91 (0.39, 2.10) |
MRI | 11 (46%) | 249 (67%) | 0.42 (0.18, 0.97) |
MRCP | 15 (63%) | 278 (75%) | 0.57 (0.24, 1.34) |
EUS | 0 (0%) | 38 (10%) | 0.00 (0.00, 1.22) |
Findings (CT/MRI) | |||
Focal Acute Pancreatitis | 3/15 (20%) | 43/220 (16%) | 1.28 (0.22, 5.02) |
Inflammatory changes in Pancreas | 6/15 (40%) | 98/298 (37%) | 1.14 (0.39, 3.31) |
Pancreatic Gland Enlargement | 5/15 (33%) | 69/267 (26%) | 1.43 (0.37, 4.80) |
Pancreatic Atrophy Present | 8/16 (50%) | 58/269 (22%) | 3.64 (1.13, 11.59) |
Calcifications in Pancreas present | 1/15 (7%) | 22/268 (8%) | 0.80 (0.02, 5.75) |
Duct Irregularities | 2/16 (12%) | 92/267 (34%) | 0.27 (0.06, 1.22) |
Pancreatic duct dilatation present | 3/16 (19%) | 97/268 (36%) | 0.41 (0.11, 1.46) |
Lesions present in the pancreas | 0/16 (0%) | 9/272 (3%) | 0.00 (0.00, 7.04) |
Gallstones/Sludge | 1/16 (6%) | 23/266 (9%) | 0.70 (0.02, 5.01) |
Intraheptic biliary dilatation | 1/16 (6%) | 27/269 (10%) | 0.60 (0.01, 4.20) |
Changes suggestive of cirrhosis and/or portal hypertension | 2/16 (12%) | 17/266 (6%) | 2.09 (0.21, 10.33) |
Findings (CT/MRI/ MRCP/ ERCP) | |||
Pancreatic duct obstruction (stricture) | 1/22 (5%) | 63/321 (20%) | 0.20 (0.00, 1.26) |
CBD stricture (Intrapancreatic portion) | 0/22 (0%) | 17/334 (5%) | 0.00 (0.00, 2.97) |
Dilated CBD | 5/22 (23%) | 49/336 (15%) | 1.72 (0.47, 5.15) |
CBD Stone | 0/22 (0%) | 20/337 (6%) | 0.00 (0.00, 2.49) |
Findings (CT/MRI/EUS) | |||
Peripancreatic inflammation/fat stranding | 7/15 (47%) | 90/274 (33%) | 1.79 (0.63, 5.09) |
Findings (CT/MRI/MRCP/ ERCP /EUS) | |||
Cysts/Pseudocysts | 4/22 (18%) | 50/338 (15%) | 1.28 (0.30, 4.11) |
Findings (MRCP/ERCP) | |||
Main Pancreatic Duct - Abnormal | 7/18 (39%) | 149/291 (51%) | 0.61 (0.23, 1.61) |
Abnormal Side Branches | 4/16 (25%) | 76/284 (27%) | 0.91 (0.21, 3.13) |
Intraductal filling defects of Calculi | 2/16 (12%) | 54/290 (19%) | 0.62 (0.07, 2.85) |
ERCP= Endoscopic retrograde cholangiopancreatography; CT = Computed tomography; MRI= Magnetic resonance imaging; MRCP= Magnetic resonance cholangiopancreatography; EUS= Endoscopic ultrasound;